These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6733707)

  • 1. Prospidin chemotherapy in recurrent head and neck carcinoma: a phase II study.
    Gröhn P; Heinonen E; Appelqvist P; Hajba A; Holopainen E; Paavolainen M; Palva T
    Cancer Treat Rep; 1984 Jun; 68(6):915-7. PubMed ID: 6733707
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospidin combined to preoperative irradiation in head and neck cancer.
    Parvinen LM; Kortekangas AE; Nordman E
    Strahlentherapie; 1985 Oct; 161(10):623-4. PubMed ID: 4060201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The basic agent prospidin in the therapy of rheumatoid arthritis (late observations)].
    Benenson EV; Beĭshenov AD; Kumanalieva AK; Verkhusha AI
    Revmatologiia (Mosk); 1988; (4):6-12. PubMed ID: 3073503
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
    Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
    Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy.
    Shah MK; Engstrom PF; Catalano RB; Paul AR; Bellet RE; Creech RH
    Cancer Treat Rep; 1982 Mar; 66(3):557-8. PubMed ID: 7060043
    [No Abstract]   [Full Text] [Related]  

  • 6. [Phase II trial of mitoguazone in patients with recurrent extensive cervicofacial tumors].
    Coninx P; Nasca S; Jezekova D; Roelandt H; Morel M; Legros M; Cattan A
    Bull Cancer; 1985; 72(2):153-4. PubMed ID: 4005436
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new basic agent, prospidin, in the therapy of rheumatoid arthritis. Research on its clinical effectiveness in a controlled and double-blind trial].
    Benenson EV; Nemtsov BF; Maksimov TA; Kurmanalieva AK; Beĭshenov AD
    Revmatologiia (Mosk); 1985; (3):36-40. PubMed ID: 3903928
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
    Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new basic drug prospidin in the treatment of rheumatoid arthritis. III. Comparative analysis of prospidin and cyclophosphamide].
    Benenson EV; Nemtsov BF; Ualieva TM
    Ter Arkh; 1987; 59(4):76-9. PubMed ID: 3035735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
    Benner SE; Lippman SM; Huber MH; Hong WK
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):22-5. PubMed ID: 7481857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of S-1 and nedaplatin for patients with recurrence of head and neck cancer.
    Kodaira T; Fuwa N; Tachibana H; Hidano S
    Anticancer Res; 2006; 26(3B):2265-8. PubMed ID: 16821599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel and carboplatin in recurrent or metastatic head and neck cancer: a phase II study.
    Fountzilas G; Athanassiadis A; Samantas E; Skarlos D; Kalogera-Fountzila A; Nikolaou A; Bacoyiannis H; Stathopoulos G; Kosmidis P; Daniilidis J
    Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-65-S2-67. PubMed ID: 9045340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Baghi M; Hambek M; Wagenblast J; May A; Gstoettner W; Knecht R
    Anticancer Res; 2006; 26(1B):585-90. PubMed ID: 16739325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of head and neck carcinomas. Association of adriamycine, vincristine and methotrexate (author's transl)].
    Durand M; Chauvergne J; Renaud-Salis JL
    Ann Otolaryngol Chir Cervicofac; 1980; 97(4-5):277-83. PubMed ID: 7406411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The new basic agent prospidin in the therapy of rheumatoid arthritis. An evaluation of the clinical effectiveness and the mechanism of action of prospidin].
    Benenson EV; Nemtsov BF; Krasnov SL
    Ter Arkh; 1986; 58(12):103-8. PubMed ID: 3547750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.).
    Galetta D; Giotta F; Rosati G; Gebbia V; Manzione L; Di Bisceglie M; Borsellino N; Colucci G
    Anticancer Res; 2005; 25(6C):4445-9. PubMed ID: 16334124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immune status during the combined use of microwave hyperthermia and prospidin in animals with transplantable tumors].
    Davydov VF; Iakhontov NE; Pugachev VF; Monakhov AA; Kuzin VB
    Med Radiol (Mosk); 1987 Oct; 32(10):56-8. PubMed ID: 3657439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of weekly paclitaxel and epirubicin in recurrent or refractory squamous cell carcinoma of the head and neck.
    Wang TF; Chu SC; Kao RH; Yao CY; Li CC
    Jpn J Clin Oncol; 2008 Jul; 38(7):459-63. PubMed ID: 18586668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.